Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03138408
Title SC-004 Alone or With ABBV-181 in Subjects With Epithelial Ovarian, Fallopian Tube, Primary Peritoneal and Endometrial Cancers
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors AbbVie
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama /ID# 202249 Birmingham Alabama 35294 United States Details
Highlands Oncology Group /ID# 209165 Fayetteville Arkansas 72703-4005 United States Details
City of Hope /ID# 202493 Duarte California 91010 United States Details
University of Chicago /ID# 200735 Chicago Illinois 60637 United States Details
Henry Ford Health System /ID# 202480 Detroit Michigan 48202 United States Details
Mayo Clinic - Rochester /ID# 200732 Rochester Minnesota 55905-0001 United States Details
Washington University School /ID# 164091 Saint Louis Missouri 63108 United States Details
The Ohio State University - Columbus /ID# 164089 Columbus Ohio 43210 United States Details
Univ Oklahoma HSC /ID# 164090 Oklahoma City Oklahoma 73104 United States Details
Tennessee Oncology-Nashville Centennial /ID# 164088 Nashville Tennessee 37203-1632 United States Details
MD Anderson Cancer Center /ID# 200048 Houston Texas 77030 United States Details
Huntsman Cancer Institute /ID# 209164 Salt Lake City Utah 84112-5500 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field